相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial
Amelie Pielen et al.
ACTA OPHTHALMOLOGICA (2015)
Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion
Hee Jin Sohn et al.
ACTA OPHTHALMOLOGICA (2014)
Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study)
Matus Rehak et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Time to Clinically Significant Visual Acuity Gains after Ranibizumab Treatment for Retinal Vein Occlusion: BRAVO and CRUISE Trials
Allen B. Thach et al.
OPHTHALMOLOGY (2014)
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up - The SOLO study
Athanasios Bezatis et al.
ACTA OPHTHALMOLOGICA (2013)
PROSPECTIVE STUDY OF PERIPHERAL PANRETINAL PHOTOCOAGULATION OF AREAS OF NONPERFUSION IN CENTRAL RETINAL VEIN OCCLUSION
Richard F. Spaide
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review
Taygan Yilmaz et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion Results from the BRAVO and CRUISE Trials
Rohit Varma et al.
OPHTHALMOLOGY (2012)
Comorbidity in patients with branch retinal vein occlusion: case-control study
Mette Bertelsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up
Alfredo Pece et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
Gesine B. Jaissle et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
David M. Brown et al.
OPHTHALMOLOGY (2011)
Response of Retinal Vessels and Retrobulbar Hemodynamics to Intravitreal Anti-VEGF Treatment in Eyes with Branch Retinal Vein Occlusion
Stefan Sacu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Antagonism of Vascular Endothelial Growth Factor for Macular Edema Caused by Retinal Vein Occlusions: Two-Year Outcomes
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic Review
Sophie L. Rogers et al.
OPHTHALMOLOGY (2010)
Intravitreal bevacizumab (Avastin®) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial
F. Prager et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Early Intravitreal Bevacizumab for Non-Ischaemic Branch Retinal Vein Occlusion
Florian Rensch et al.
OPHTHALMOLOGICA (2009)
Early bevacizumab treatment of central retinal vein occlusion
Daniela C. Ferrara et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
分享论文
